Beilstein J. Org. Chem.2013,9, 1601–1606, doi:10.3762/bjoc.9.182
; organocatalytic1,4-conjugateaddition; Introduction
2-Pyranone is a privilege structure that is often present in natural products and pharmaceuticals, many of which exhibit diverse molecular architectures and biological profiles [1][2]. For example, katsumadain A (1) and B (2), which were isolated from Alpinia
katsumadain A, we then moved towards the alternative approach as described in Scheme 1. We envisioned that in this scenario an organocatalytic1,4-conjugateaddition [24][25][26][27] between 3 and 7 would circumvent both the reactivity and selectivity issues, which we have struggled with in the aforementioned
studies. To validate this hypothesis, we performed a systematic investigation of the organocatalytic1,4-conjugateaddition by examining various reaction parameters, including organocatalyst, acid additive, solvent temperature, and reaction temperature (Table 1). The first reaction was performed by
PDF
Graphical Abstract
Scheme 1:
Proposed biosynthetic pathway and strategic analysis for synthesis of katsumadain A.